HIV Vaccines (Experimental)

This page catalogs 1 HIV vaccine candidate that reached Phase III clinical trials. Despite decades of research, no HIV vaccine has achieved regulatory approval. AIDSVAX, the first HIV vaccine to complete Phase III trials, failed to demonstrate protective efficacy in 2003. HIV vaccine development remains an active area of research with multiple candidates in earlier-stage clinical trials.

Last updated: April 2026.